000 | 01114 a2200325 4500 | ||
---|---|---|---|
005 | 20250513120409.0 | ||
264 | 0 | _c19970609 | |
008 | 199706s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(97)90016-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScott, A M | |
245 | 0 | 0 |
_aClinical promise of tumour immunology. _h[electronic resource] |
260 |
_bLancet (London, England) _cMay 1997 |
||
300 |
_aSII19-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Neoplasm _ximmunology |
650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanoma _xtherapy |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 |
_aNeoplasms, Experimental _ximmunology |
650 | 0 | 4 | _aVaccination |
700 | 1 | _aCebon, J | |
773 | 0 |
_tLancet (London, England) _gvol. 349 Suppl 2 _gp. SII19-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(97)90016-7 _zAvailable from publisher's website |
999 |
_c9145649 _d9145649 |